Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study

2021; Elsevier BV; Volume: 6; Linguagem: Inglês

10.1016/j.lana.2021.100154

ISSN

2667-193X

Autores

Thiago Cerqueira‐Silva, Vinícius de Araújo Oliveira, Viviane Boaventura, Júlia Moreira Pescarini, Juracy Bertoldo, Tales Mota Machado, Renzo Flores-Ortiz, Gerson Oliveira Penna, Maria Yury Ichihara, Jacson Venâncio de Barros, Maurício L. Barreto, Guilherme Loureiro Werneck, Manoel Barral‐Netto,

Tópico(s)

Vaccine Coverage and Hesitancy

Resumo

Aging influences COVID-19 severity and response to vaccination, but previous vaccine effectiveness (VE) analyzes lack the power to evaluate its role in subgroups within the elderly age group. Here we analyzed the impact of age on viral vector and inactivated virus vaccines' effectiveness, the main platforms used in low- and middle-income countries.

Referência(s)